Somaxon Pharmaceuticals, Inc. (SOMX) announced the appointment of Tran Nguyen as Vice President and Chief Financial Officer.
Nguyen was most recently Chief Financial Officer of Metabasis Therapeutics, Inc., a publicly traded biopharmaceutical company that was acquired by Ligand Pharmaceuticals Incorporated in January 2010.
The company also announced other executive management team updates each effective April 1, 2010.
The company noted that Jeffrey Raser was promoted to the newly created role of Senior Vice President and Chief Commercial Officer. In this role, Raser will be responsible for all of Somaxon's sales, marketing, managed care and other commercial operations. Brian Dorsey was promoted to Senior Vice President, Technical Operations. In this role, Dorsey will manage all of Somaxon's activities relating to research and development, regulatory affairs, medical affairs, manufacturing and quality.
Further, Matthew Onaitis was promoted to Senior Vice President and General Counsel. In this role, Onaitis will manage all of Somaxon's legal, compliance, intellectual property and business development activities.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.